Clinical Trial Update: Study of Tumor Metabolism by Isotopic Tagging in Patients With High-grade Glioma (CARBONOMIC) [Phase 1]

View source ↗

Summary

This is a terminated Phase 1 clinical trial update for CARBONOMIC, a study of tumor metabolism by isotopic tagging in patients with high-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Snippet

Sponsor: University Hospital, Grenoble | Conditions: High-grade Glioma | Phase 1 | Status: TERMINATED